AbCellera Biologics Ownership | Who Owns AbCellera Biologics?


OverviewForecastRevenueFinancialsChartTranscripts

AbCellera Biologics Ownership Summary


AbCellera Biologics is owned by 4.25% institutional investors, 22.90% insiders, and 72.85% retail investors. Baker bros. advisors lp is the largest institutional shareholder, holding 9.22% of ABCL shares. American Funds SMALLCAP World A is the top mutual fund, with 4.48% of its assets in AbCellera Biologics shares.

ABCL Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockAbCellera Biologics4.25%22.90%72.85%
SectorHealthcare Stocks 42.54%10.83%46.63%
IndustryBiotech Stocks 45.22%10.75%44.04%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Baker bros. advisors lp27.53M9.22%$138.45M
Capital world investors13.36M4.48%$67.21M
Baillie gifford10.42M3.49%$52.43B
Two sigma investments, lp5.18M1.73%$26.03M
Two sigma advisers, lp4.80M1.61%$24.14M
Arrowmark colorado4.11M1.38%$20.65M
Blackrock3.80M1.30%$11.26M
Blackrock funding, inc. /de3.64M1.22%$18.32M
Renaissance3.36M1.13%$16.90M
Morgan stanley2.79M0.94%$14.04M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Baker bros. advisors lp27.53M1.00%$138.45M
Guardian partners1.79M0.90%$10.65B
Guardian capital advisors lp1.79M0.53%$5.00M
Intellectus partners543.13K0.53%$2.73M
Tang capital management2.60M0.50%$13.08M
Arrowmark colorado4.11M0.38%$20.65M
Archpoint investors115.06K0.16%$578.73K
Brandywine managers28.49K0.14%$143.29K
Green alpha advisors22.77K0.11%$114.56K
Pier 88 investment partners108.87K0.10%$547.62K

Top Buyers

HolderShares% AssetsChange
Morgan stanley2.79M0.00%1.80M
Norges bank1.28M0.00%1.28M
Driehaus capital management1.73M0.06%1.23M
Two sigma investments, lp5.18M0.04%1.06M
Arrowstreet capital, limited partnership736.95K0.00%736.95K

Top Sellers

HolderShares% AssetsChange
Voya investment management---10.62M
Ubs asset management americas---8.47M
Founders fund vii management---3.77M
Orbimed advisors---3.34M
Prosight management, lp---2.82M

New Positions

HolderShares% AssetsChangeValue
Norges bank1.28M0.00%1.28M$3.76M
Arrowstreet capital, limited partnership736.95K0.00%736.95K$3.71M
Tudor investment corp et al730.12K0.01%730.12K$3.67M
Jump financial675.60K0.04%675.60K$3.40M
Dnb asset management as656.21K0.01%656.21K$3.30M

Sold Out

HolderChange
Gamma investing-46.00
Morton brown family wealth-75.00
Continuum advisory-93.00
Atticus wealth management-100.00
Rhumbline advisers-135.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 202553-60.15%12,673,344-88.22%40.32%24-57.89%17-61.36%
Jun 30, 2025131-2.24%107,406,760-13.88%362.06%5420.00%45-10.00%
Mar 31, 2025134-10.67%124,719,7849.52%412.81%46-34.29%4922.50%
Dec 31, 20241472.80%113,857,4378.74%383.06%69-4.17%3918.18%
Sep 30, 2024140-8.50%104,569,721-8.52%352.33%7020.69%34-29.17%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
American Funds SMALLCAP World A13.36M4.48%-
Allianz Global Artfcl Intlgc W EUR6.17M2.07%-7.81K
UBS (Lux) Digital Health Equity SB USD4.50M1.51%-
SMDS Global AI Equity Mother4.49M1.50%-
Baillie Gifford Positive Change3.89M1.30%-143.60K
Baillie Gifford Positive Change B Acc3.89M1.30%-128.37K
UBS Lux Dgtl Hlth Eq Fd seeding P acc3.40M1.14%-72.96K
American Funds IS® Asset Allocation 12.87M0.97%-
Baillie Gifford WW Pstv Chg B USD Acc2.26M0.76%-72.26K
ACATIS Datini Valueflex Fonds A1.86M0.62%860.00K

Recent Insider Transactions


DateNameRoleActivityValue
Nov 26, 2025Montalbano John S.-Buy$178.46K
Mar 11, 2025Thermopylae Holdings Ltd.-Buy$742.24K
Mar 10, 2025Montalbano John S.-Buy$57.50K
Mar 06, 2025Montalbano John S.-Buy$140.57K
Aug 29, 2024Thermopylae Holdings Ltd.-Buy$739.98K

Insider Transactions Trends


DateBuySell
2025 Q41-
2025 Q2--
2025 Q13-
2024 Q4--
2024 Q31-

ABCL Ownership FAQ


Who Owns AbCellera Biologics?

AbCellera Biologics shareholders are primarily institutional investors at 4.25%, followed by 22.90% insiders and 72.85% retail investors. The average institutional ownership in AbCellera Biologics's industry, Biotech Stocks , is 45.22%, which AbCellera Biologics falls below.

Who owns the most shares of AbCellera Biologics?

AbCellera Biologics’s largest shareholders are Baker bros. advisors lp (27.53M shares, 9.22%), Capital world investors (13.36M shares, 4.48%), and Baillie gifford (10.42M shares, 3.49%). Together, they hold 17.19% of AbCellera Biologics’s total shares outstanding.

Does Blackrock own AbCellera Biologics?

Yes, BlackRock owns 1.30% of AbCellera Biologics, totaling 3.8M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 11.26M$. In the last quarter, BlackRock decreased its holdings by -97.087K shares, a -2.49% change.

Who is AbCellera Biologics’s biggest shareholder by percentage of total assets invested?

Baker bros. advisors lp is AbCellera Biologics’s biggest shareholder by percentage of total assets invested, with 1.00% of its assets in 27.53M AbCellera Biologics shares, valued at 138.45M$.

Who is the top mutual fund holder of AbCellera Biologics shares?

American Funds SMALLCAP World A is the top mutual fund holder of AbCellera Biologics shares, with 4.48% of its total shares outstanding invested in 13.36M AbCellera Biologics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools